Alzheimer’s Drug Discovery Foundation: Prevention

October 30, 2025

Deadline

02/23/2026

Amount

$5,000,000

Sponsor

Alzheimer's Drug Discovery Foundation

Research Area

Alzheimer's, Alzheimer's Prevention, Human Studies

Funder Url

https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.alzdiscovery.org%2Fresearch-and-grants%2Ffunding-opportunities%2Fprevention-pipeline&data=05%7C02%7CVeronica.Alvarez%40med.usc.edu%7C8c0029369a894126d49308de1711c307%7Ca63249ac3e0b4a249e0cc90ab9891e30%7C1%7C0%7C638973562221851701%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=JGc57F91C2GyLW%2Bm1z%2F51U6s6eCfdgn%2F8oBtHd7uZSU%3D&reserved=0

If you are interested in the following opportunity, please contact Carole King at carole.king@med.usc.edu.

LOI due: February 23, 2026
Budget: $5,000,000 (no indirects)
Project period: Multi-year

Funds human studies on precision prevention, combination therapies, and comparative effectiveness to reduce Alzheimer’s and related dementia risk. Eligible studies target primary or secondary prevention populations, focus on modifiable risk factors, and measure outcomes such as cognition or biomarkers. Lifestyle-only interventions are excluded, but combinations with drugs, supplements, or devices are eligible. Priority goes to novel or repurposed therapeutics with strong commercial or IP potential.